ZimVie Inc. involved in the Dental and Spine markets which develops, manufactures and delivers a portfolio of products and solutions designed to treat Spine pathologies and support Dental tooth replacement and restoration procedures. ZimVie Inc. is headquartered in Westminster, Colorado.
| Revenue (Most Recent Fiscal Year) | $449.75M |
| Net Income (Most Recent Fiscal Year) | $-25.83M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 20.61 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.21 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.30 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.21 |
| Pre-Tax Margin (Trailing 12 Months) | -1.96% |
| Net Margin (Trailing 12 Months) | -4.39% |
| Return on Equity (Trailing 12 Months) | 6.37% |
| Return on Assets (Trailing 12 Months) | 3.34% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.37 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.60 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.56 |
| Inventory Turnover (Trailing 12 Months) | 1.96 |
| Book Value per Share (Most Recent Fiscal Quarter) | $13.83 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.70 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 28.21M |
| Free Float | 26.68M |
| Market Capitalization | $534.88M |
| Average Volume (Last 20 Days) | 0.30M |
| Beta (Past 60 Months) | 2.17 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 5.41% |
| Percentage Held By Institutions (Latest 13F Reports) | 95.63% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |